埃拉基酸在肝脏疾病中的治疗潜力
Karolina Wojtunik-Kulesza1, Przemysław Niziński2, Anna Krajewska3
1Department of Inorganic Chemistry, Medical University of Lublin, Chodźki 4a, 20-093 Lublin, Poland.
Molecules (Basel, Switzerland)
|June 27, 2025
概括
埃拉基酸通过减少炎症和氧化应激减轻肝脏健康的承诺. 需要进一步的人类研究来证实它对肝脏疾病的有效性,例如与代谢功能障碍相关的脂肪性肝病.
科学领域:
- 自然产品化学 自然产品化学
- 肝病学 肝病学是一种肝病学.
- 营养科学 营养科学
背景情况:
- 酸 (EA) 是一种具有抗氧化,抗炎和神经保护性能的多.
- EA通过多种机制表现出肝脏保护作用,包括抗氧化防御,炎症调节和亡调节.
- 低生物可用性限制了EA的临床使用,但urolithins和先进的输送系统可能提供解决方案.
研究的目的:
- 审查基酸 (EA) 对肝脏疾病的治疗潜力.
- 突出EA在保护肝脏方面的作用机制.
- 讨论EA在治疗与代谢功能障碍相关的脂肪性肝病 (MASLD) 中的作用.
主要方法:
- 关于酸和肝脏健康的临床前和临床研究的文献综述.
- 分析EA的分子机制,包括Nrf2/ARE激活,NF-κB抑制和TGF-β/Smad信号调制.
- 检查EA对肠道微生物群的影响及其与肝炎相关性的研究.
主要成果:
- EA清除活性氧物种 (ROS) 并增强抗氧化防御.
- EA调节炎症通路 (NF-κB,TNF-α,IL-6) 并调节细胞亡和纤维化.
- EA对肠道微生物群产生积极影响,减少肠道透性和肝脏炎症.
结论:
- 酸对肝脏疾病,特别是MASLD具有显著的治疗潜力.
- 乌罗利थिन和改进的输送系统可能会提高EA的临床疗效.
- 需要进一步进行广泛的人体研究,以验证EA在肝病管理中的安全性和有效性.
更多相关视频
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
476
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
1.1K
相关概念视频
Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
